Error: Could not add to watchlist. X

Novogen Ltd

+ Watchlist
NVGN:US
NASDAQ CM
3.48
USD
0.09
2.49%
As of 20:10:00 ET on 07/31/2015.
Open
3.56
Day Range
3.41 - 3.56
Volume
75,460
Previous Close
3.57
52Wk Range
1.51 - 9.50
1 Yr Return
7.41%
Open
3.56
Day Range
3.41 - 3.56
Volume
75,460
Previous Close
3.57
52Wk Range
1.51 - 9.50
1 Yr Return
7.41%
YTD Return
67.31%
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
59.037
Shares Outstanding (m)
16.965
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
ADDRESS
16 - 20 Edgeworth David Ave
Hornsby, NSW 2077
Australia
PHONE
61-2-9472-4100
  • Ian M Phillips
    Interim Chairman
  • Iain Gladstone Ross
    Acting CEO
  • David Brown
    Chief Scientific Officer
  • Cristyn Humphreys
    COO:Administration & Finance
  • W Andrew Heaton
    VP:Drug Discovery
Show More